Holistic Care Partner Program Feasibility and Acceptability

May 29, 2026 updated by: NYU Langone Health

Holistic Care Partners: A Black Woman-led Nurse Navigation Program to Improve Care, Reduce Harm, and Enhance Perinatal Wellbeing for Black Birthing People

The study aims to build on the knowledge of the United States' ongoing maternal health crisis for Black birthing people. The study team will take a holistic focused approach to build on the experiences of Black women perinatal nurses, Black women/birthing people, and their care partners enrolled in the Holistic Care Partner Program (HCP) to understand the program's feasibility and acceptability. HCP was developed at NYU Langone Health by Blank women-led perinatal nurses to address the effects of obstetric racism and the associated fear of pregnancy and birth faced by Black women and birthing people. Utilizing a mixed-methods approach, the study will focus on understanding HCP's acceptability and feasibility via surveys and qualitative interviews with Black women and birthing people and their partners/support persons to identify strategies and recommendations for intervention improvement. Exploratory analysis of maternal and infant outcomes will be conducted using a propensity score matched historical control group.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Audrey Lyndon, PhD, RNC, FAAN
  • Phone Number: 212-992-5940
  • Email: al6148@nyu.edu

Study Contact Backup

Study Locations

    • New York
      • New York, New York, United States, 10016
        • Recruiting
        • NYU Langone Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Study Population

Black birthing women/people and their partners/support persons

Description

Inclusion Criteria:

  1. Identify as Black or within the Black/African Diaspora
  2. Enrolled in the HCP program while pregnant or within 6 weeks postpartum
  3. Enrolled in the Faculty Group Practice at NYU Langone Health (NYULH) for obstetric care
  4. Plan to give birth at NYULH Tisch or gave birth at NYULH Tisch if postpartum at screening.
  5. Comfortable reading and/or speaking English (approximately 95% of Black women speak English)
  6. Are 18 years or older

Exclusion Criteria:

  1. Does not identify as Black or within the Black/African Diaspora
  2. Did not enroll in the HCP program while pregnant or within 6 weeks postpartum.
  3. Not enrolled in the FGP NYULH for obstetric care
  4. Does not plan to give birth at NYULH Tisch or did not give birth at NYULH Tisch if postpartum at time of screening.
  5. Is not 18 years or older
  6. Multiple gestation
  7. Significant fetal anomaly requiring exceptional care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Black Birthing Patients enrolled in Holistic Care Partner Program (HCP)
Black birthing patients enrolled in HCP will be invited to participate in a brief survey and/or a qualitative interview throughout 1 year of their enrollment.
The nurse navigators assess patient medical, social, and structural needs at enrollment, 20-, 28-, and 36-weeks gestation; and at 1-week, and 3, 6, and 9 months postpartum. They provide coordination, support, and referrals, and enhanced communication with or escalate concerns to the primary physician as indicated. The nurse navigator tailors additional visits to the individual needs of the patients (for example, managing comorbidities, social isolation, breastfeeding support). Participants also have access to a Black woman-led support group during pregnancy and the first postpartum year, and access to Black woman-led childbirth and lactation classes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Theoretical Framework for Acceptability (TFA) questionnaire score
Time Frame: Visit 3 (6-12 weeks postpartum)

Anticipated and experienced acceptability will be measured using the Theoretical Framework for Acceptability questionnaire. This is a 13-item Likert-type questionnaire designed to assess acceptability of the intervention from the participants' perspective along the 7 component constructs (affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy).

Total score ranges from 13-65, with higher scores indicating greater acceptability of the intervention.

Visit 3 (6-12 weeks postpartum)
Number of participants who complete the study
Time Frame: Visit 4 (9-12 months postpartum)
Visit 4 (9-12 months postpartum)
Attendance rate for nurse navigator visits
Time Frame: Visit 4 (9-12 months postpartum)
Visit 4 (9-12 months postpartum)
Attendance rate at lactation classes
Time Frame: Visit 4 (9-12 months postpartum)
Visit 4 (9-12 months postpartum)
Attendance rate at the support group
Time Frame: Visit 4 (9-12 months postpartum)
Visit 4 (9-12 months postpartum)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Audrey Lyndon, PhD, RNC, FAAN, NYU Langone Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2024

Primary Completion (Estimated)

August 18, 2026

Study Completion (Estimated)

August 18, 2026

Study Registration Dates

First Submitted

July 22, 2024

First Submitted That Met QC Criteria

July 22, 2024

First Posted (Actual)

July 25, 2024

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 29, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 23-00821
  • 1R21NR020960-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The redacted interview transcripts from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data and who provide a methodologically sound proposal executes a data use agreement with NYU Langone Health. Requests may be directed to: al6148@nyu.edu. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

IPD Sharing Time Frame

Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.

IPD Sharing Access Criteria

The investigator who proposed to use the data and who provide a methodologically sound proposal will be provided access upon reasonable request. Requests should be directed to al6148@nyu.edu. To gain access, data requestors will need to sign a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maternal Care

Clinical Trials on Holistic care partner perinatal nurse navigation

Subscribe